Spis treści:
Spis załączników:
SFA Acquisition Initiation 04102024 espi.pdf (REPORT)
reklama
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
SFA Acquisition Initiation 04102024 espi.pdf (REPORT)
przewiń, aby zobaczyć całą tabelę
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 112 | / | 2024 | ||||||||
| Date of issue: | 2024-10-04 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification for initiation of acquisition transaction | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| “Sopharma” AD (the Company, SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that following its growth strategy and its goal of becoming a stronger regional player, the Company initiates a transaction for acquisition of a pharmaceutical product portfolio consisting of both CHC and prescription products in the following therapeutic areas: Sex hormones and modulators of the genital system, Urologicals and Antivirals for systemic use. The acquisition totals 68 marketing authorizations with 14 well-known brands in 10 of the traditional markets of the Company. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA Acquisition Initiation 04102024 espi.pdfSFA_Acquisition_Initiation_04102024_espi.pdf | Notification for initiation of acquisition transaction | ||||||||||
przewiń, aby zobaczyć całą tabelę
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
przewiń, aby zobaczyć całą tabelę
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-10-04 | Ognian Donev | Executive Director | |||